|
1
|
In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers.
|
Nat Med
|
2012
|
2.13
|
|
2
|
Noninvasive urinary metabonomic diagnosis of human bladder cancer.
|
J Proteome Res
|
2010
|
1.26
|
|
3
|
The impact of aqueous solubility and dose on the pharmacokinetic profiles of resveratrol.
|
Pharm Res
|
2008
|
1.24
|
|
4
|
Determination of pterostilbene in rat plasma by a simple HPLC-UV method and its application in pre-clinical pharmacokinetic study.
|
Biomed Chromatogr
|
2009
|
1.17
|
|
5
|
Evaluation of the in vitro activity and in vivo bioavailability of realgar nanoparticles prepared by cryo-grinding.
|
Eur J Pharm Sci
|
2006
|
1.10
|
|
6
|
Histone deacetylase inhibitors MS-275 and SAHA induced growth arrest and suppressed lipopolysaccharide-stimulated NF-kappaB p65 nuclear accumulation in human rheumatoid arthritis synovial fibroblastic E11 cells.
|
Rheumatology (Oxford)
|
2010
|
1.10
|
|
7
|
Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice.
|
J Mol Med (Berl)
|
2011
|
1.05
|
|
8
|
The medicinal use of realgar (As₄S₄) and its recent development as an anticancer agent.
|
J Ethnopharmacol
|
2011
|
1.03
|
|
9
|
Design of a multifunctional PLGA nanoparticulate drug delivery system: evaluation of its physicochemical properties and anticancer activity to malignant cancer cells.
|
Pharm Res
|
2009
|
1.03
|
|
10
|
Development and validation of a gas chromatography/mass spectrometry metabonomic platform for the global profiling of urinary metabolites.
|
Rapid Commun Mass Spectrom
|
2008
|
0.95
|
|
11
|
Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients.
|
Clin Pharmacokinet
|
2006
|
0.93
|
|
12
|
Ursolic acid inhibits the initiation, progression of prostate cancer and prolongs the survival of TRAMP mice by modulating pro-inflammatory pathways.
|
PLoS One
|
2012
|
0.90
|
|
13
|
A nanocapsular combinatorial sequential drug delivery system for antiangiogenesis and anticancer activities.
|
Biomaterials
|
2010
|
0.89
|
|
14
|
Inclusion of acitretin into cyclodextrins: phase solubility, photostability, and physicochemical characterization.
|
J Pharm Sci
|
2003
|
0.89
|
|
15
|
Self-assembled core-shell vascular-targeted nanocapsules for temporal antivasculature and anticancer activities.
|
Small
|
2010
|
0.89
|
|
16
|
Pharmacokinetics of pterostilbene in Sprague-Dawley rats: the impacts of aqueous solubility, fasting, dose escalation, and dosing route on bioavailability.
|
Mol Nutr Food Res
|
2013
|
0.88
|
|
17
|
A simple and sensitive HPLC-UV method for the quantification of piceatannol analog trans-3,5,3',4'-tetramethoxystilbene in rat plasma and its application for a pre-clinical pharmacokinetic study.
|
J Pharm Biomed Anal
|
2009
|
0.88
|
|
18
|
Fluorescent nanogel of arsenic sulfide nanoclusters.
|
Angew Chem Int Ed Engl
|
2009
|
0.87
|
|
19
|
Glucuronidation by UGT1A1 is the dominant pathway of the metabolic disposition of belinostat in liver cancer patients.
|
PLoS One
|
2013
|
0.86
|
|
20
|
A rapid HPLC method for the quantification of 3,5,4'-trimethoxy-trans-stilbene (TMS) in rat plasma and its application in pharmacokinetic study.
|
J Pharm Biomed Anal
|
2008
|
0.86
|
|
21
|
Determination of Z-3,5,4'-trimethoxystilbene in rat plasma by a simple HPLC method: application in a pre-clinical pharmacokinetic study.
|
J Pharm Biomed Anal
|
2010
|
0.86
|
|
22
|
Determination of trans-2,4,3',4',5'-pentamethoxystilbene in rat plasma and its application to a pharmacokinetic study.
|
J Pharm Biomed Anal
|
2011
|
0.85
|
|
23
|
Method development and validation for rapid quantification of hydroxychloroquine in human blood using liquid chromatography-tandem mass spectrometry.
|
J Pharm Biomed Anal
|
2011
|
0.85
|
|
24
|
Urinary metabotyping of bladder cancer using two-dimensional gas chromatography time-of-flight mass spectrometry.
|
J Proteome Res
|
2013
|
0.85
|
|
25
|
Nanoparticulate delivery system targeted to tumor neovasculature for combined anticancer and antiangiogenesis therapy.
|
Pharm Res
|
2010
|
0.85
|
|
26
|
Metabonomic profiling of bladder cancer.
|
J Proteome Res
|
2014
|
0.84
|
|
27
|
Preclinical pharmacokinetic evaluation of resveratrol trimethyl ether in sprague-dawley rats: the impacts of aqueous solubility, dose escalation, food and repeated dosing on oral bioavailability.
|
J Pharm Sci
|
2011
|
0.84
|
|
28
|
Integrin targeted drug and gene delivery.
|
Expert Opin Drug Deliv
|
2010
|
0.84
|
|
29
|
Quantification of oxyresveratrol analog trans-2,4,3',5'-tetramethoxystilbene in rat plasma by a rapid HPLC method: application in a pre-clinical pharmacokinetic study.
|
Biomed Chromatogr
|
2010
|
0.83
|
|
30
|
Evaluation of the pharmacokinetics of all-trans-retinoic acid (ATRA) in Wistar rats after intravenous administration of ATRA loaded into tributyrin submicron emulsion and its cellular activity on caco-2 and HepG2 cell lines.
|
J Pharm Sci
|
2008
|
0.82
|
|
31
|
Metabonomic profiling of TASTPM transgenic Alzheimer's disease mouse model.
|
J Proteome Res
|
2012
|
0.82
|
|
32
|
Quantification of trans-2,6-difluoro-4'-N,N-dimethylaminostilbene in rat plasma: application to a pharmacokinetic study.
|
J Pharm Biomed Anal
|
2012
|
0.82
|
|
33
|
Arsenic(II) sulfide quantum dots prepared by a wet process from its bulk.
|
J Am Chem Soc
|
2008
|
0.81
|
|
34
|
Quantification of trans-3,4,5,4'-Tetramethoxystilbene in rat plasma by HPLC: application to pharmacokinetic study.
|
J Agric Food Chem
|
2011
|
0.81
|
|
35
|
Microarray analysis revealed dysregulation of multiple genes associated with chemoresistance to As(2)O(3) and increased tumor aggressiveness in a newly established arsenic-resistant ovarian cancer cell line, OVCAR-3/AsR.
|
Eur J Pharm Sci
|
2011
|
0.81
|
|
36
|
Applications of monolithic materials for sample preparation.
|
J Pharm Biomed Anal
|
2013
|
0.80
|
|
37
|
Comparing the relative oxidative DNA damage caused by various arsenic species by quantifying urinary levels of 8-hydroxy-2'-deoxyguanosine with isotope-dilution liquid chromatography/mass spectrometry.
|
Pharm Res
|
2009
|
0.80
|
|
38
|
The histone deacetylase inhibitors MS-275 and SAHA suppress the p38 mitogen-activated protein kinase signaling pathway and chemotaxis in rheumatoid arthritic synovial fibroblastic E11 cells.
|
Molecules
|
2013
|
0.80
|
|
39
|
Evaluation of dried blood spots as sample matrix for gas chromatography/mass spectrometry based metabolomic profiling.
|
Anal Chem
|
2011
|
0.79
|
|
40
|
Wheat germ agglutinin-conjugated PLGA nanoparticles for enhanced intracellular delivery of paclitaxel to colon cancer cells.
|
Int J Pharm
|
2010
|
0.79
|
|
41
|
Determination of thalidomide by high performance liquid chromatography: plasma pharmacokinetic studies in the rat.
|
J Pharm Biomed Anal
|
2005
|
0.79
|
|
42
|
Differential augmentative effects of buthionine sulfoximine and ascorbic acid in As2O3-induced ovarian cancer cell death: oxidative stress-independent and -dependent cytotoxic potentiation.
|
Int J Oncol
|
2011
|
0.78
|
|
43
|
Determination of tributyrin and its metabolite butyrate in Wistar rat plasma samples by gas chromatography/mass spectrometry.
|
Rapid Commun Mass Spectrom
|
2004
|
0.78
|
|
44
|
A novel dextran-oleate-cRGDfK conjugate for self-assembly of nanodrug.
|
Nanomedicine
|
2011
|
0.78
|
|
45
|
Identification of metabolites of meisoindigo in rat, pig and human liver microsomes by UFLC-MS/MS.
|
Biochem Pharmacol
|
2009
|
0.78
|
|
46
|
A simple assay for determination of levetiracetam in rat dried blood spots by LC-MS/MS.
|
Bioanalysis
|
2013
|
0.77
|
|
47
|
A retrospective study on the usage of antiepileptic drugs in Asian children from 2000 to 2009 in the largest pediatric hospital in Singapore.
|
Pharmacoepidemiol Drug Saf
|
2012
|
0.77
|
|
48
|
Synergistic effects of suberoylanilide hydroxamic acid combined with cisplatin causing cell cycle arrest independent apoptosis in platinum-resistant ovarian cancer cells.
|
Int J Oncol
|
2012
|
0.77
|
|
49
|
CdSe/AsS core-shell quantum dots: preparation and two-photon fluorescence.
|
J Am Chem Soc
|
2009
|
0.77
|
|
50
|
Design of a pectin-based microparticle formulation using zinc ions as the cross-linking agent and glutaraldehyde as the hardening agent for colonic-specific delivery of resveratrol: in vitro and in vivo evaluations.
|
J Drug Target
|
2010
|
0.77
|
|
51
|
Metabolic footprinting of tumorigenic and nontumorigenic uroepithelial cells using two-dimensional gas chromatography time-of-flight mass spectrometry.
|
Anal Bioanal Chem
|
2010
|
0.77
|
|
52
|
Isobolographic analysis of the analgesic interactions between ketamine and tramadol.
|
J Pharm Pharmacol
|
2002
|
0.76
|
|
53
|
Formulation and optimization of zinc-pectinate beads for the controlled delivery of resveratrol.
|
AAPS PharmSciTech
|
2010
|
0.76
|
|
54
|
Evaluation of tributyrin lipid emulsion with affinity to low-density lipoprotein: pharmacokinetics in adult male Wistar rats and cellular activity on Caco-2 and HepG2 cell lines.
|
J Pharmacol Exp Ther
|
2005
|
0.76
|
|
55
|
Interaction of oxazaphosphorines with multidrug resistance-associated protein 4 (MRP4).
|
AAPS J
|
2010
|
0.75
|
|
56
|
Rapid determination of gefitinib and its main metabolite, O-desmethyl gefitinib in human plasma using liquid chromatography-tandem mass spectrometry.
|
J Chromatogr B Analyt Technol Biomed Life Sci
|
2011
|
0.75
|
|
57
|
Quantification of pinosylvin in rat plasma by liquid chromatography-tandem mass spectrometry: application to a pre-clinical pharmacokinetic study.
|
J Chromatogr B Analyt Technol Biomed Life Sci
|
2013
|
0.75
|
|
58
|
Characterization of metabolites of meisoindigo in male and female rat kidney microsomes by high-performance liquid chromatography coupled with positive electrospray ionization tandem mass spectrometry.
|
Rapid Commun Mass Spectrom
|
2008
|
0.75
|
|
59
|
Identification of circulatory and excretory metabolites of meisoindigo in rat plasma, urine and feces by high-performance liquid chromatography coupled with positive electrospray ionization tandem mass spectrometry.
|
Rapid Commun Mass Spectrom
|
2010
|
0.75
|
|
60
|
Speciation of inorganic and methylated arsenic compounds by capillary zone electrophoresis with indirect UV detection. Application to the analysis of alkali extracts of As2S2 (realgar) and As2S3 (orpiment).
|
J Chromatogr A
|
2004
|
0.75
|
|
61
|
Polymer-coated microparticles for the sustained release of nitrofurantoin.
|
J Pharm Pharmacol
|
2002
|
0.75
|
|
62
|
Cytotoxicity, qualitative structure-activity relationship (QSAR), and anti-tumor activity of bismuth dithiocarbamate complexes.
|
J Inorg Biochem
|
2007
|
0.75
|
|
63
|
Biopharmaceutics of beta-cyclodextrin derivative-based formulations of acitretin in Sprague-Dawley rats.
|
J Pharm Sci
|
2004
|
0.75
|
|
64
|
Preparation of tributyrin emulsion and characterization of the binding of the emulsion particles to low-density lipoprotein in vitro.
|
J Pharm Sci
|
2004
|
0.75
|
|
65
|
Identification of stereoisomeric metabolites of meisoindigo in rat liver microsomes by achiral and chiral liquid chromatography/tandem mass spectrometry.
|
Drug Metab Dispos
|
2008
|
0.75
|
|
66
|
Extraction of ketamine from urine using a miniature silica monolithic cartridge followed by quantification with liquid chromatography tandem mass spectrometry (LC-MS/MS).
|
J Sep Sci
|
2011
|
0.75
|
|
67
|
Estimation and comparison of carbamazepine population pharmacokinetics using dried blood spot and plasma concentrations from people with epilepsy: the clinical implication.
|
J Clin Pharmacol
|
2013
|
0.75
|
|
68
|
An automated Pearson's correlation change classification (APC3) approach for GC/MS metabonomic data using total ion chromatograms (TICs).
|
Analyst
|
2013
|
0.75
|
|
69
|
Developing a nomogram for dose individualization of phenytoin in Asian pediatric patients derived from population pharmacokinetic modeling of saturable pharmacokinetic profiles of the drug.
|
Ther Drug Monit
|
2013
|
0.75
|
|
70
|
Quantification of arsenic compounds using derivatization, solvent extraction and liquid chromatography electrospray ionization tandem mass spectrometry.
|
J Pharm Biomed Anal
|
2008
|
0.75
|
|
71
|
Biopharmaceutics of 13-cis-retinoic acid (isotretinoin) formulated with modified beta-cyclodextrins.
|
Int J Pharm
|
2007
|
0.75
|